Corcept Therapeutics specializes in cortisol-modulating drugs. Click here to read why CORT stock offers investment potential.

In what the HSA described in a Nov 27 statement as a “first-of-its-kind large-scale collaboration with online platform ...

In terms of what it is, Cushing's syndrome is caused by high levels of the cortisol hormone. Not only can it be responsible for facial hair growth, it can also cause weight gain, stretch marks, skin ...

Moebius syndrome is a rare congenital (present at birth) condition that results from underdevelopment of the facial nerves that control some of the eye movements and facial expressions. The condition ...

CORT's Cushing's syndrome drug, Korlym, is driving revenues. The NDA for relacorilant in Cushing's syndrome will be filed shortly.

is a rare but potentially life-threatening condition characterized by acute coronary syndrome in the setting of allergic reactions triggered by drugs, foods, vaccines, or environmental exposure. Our ...

radiotherapy or drug therapy. While medical therapy for Cushing's syndrome has been limited, several new agents are being investigated. This aim of this review is to analyze and present the ...

The US FDA has approved a new orphan drug to treat patients with Cushing’s disease who cannot be helped through surgery. Novartis’ Signifor (pasireotide diaspartate) injection has been ...

If you are a middle child, or have a sibling who is a middle child, you may be wondering if “middle child syndrome” is a real thing. Middle child syndrome is the belief that middle children ...

Total third-quarter revenue of $54 million was led by triple-digit percentage growth of sales of Recorlev, a cortisol ...

“This is particularly significant given that sexual dysfunction, often induced by antidepressants, frequently results in people stopping these medications and subsequently relapsing,” Barba note ...